Investigator Initiated Satellite Symposia

A large number of clinicians/scientists traveling to ISH in Vancouver, offers the opportunity for Investigator Initiated Satellite Symposia. These symposia allow investigators to show case their research group or research area of interest that will not be covered in depth by the ISH meeting.

These symposia are held either before or after the main ISH 2010 meeting. The general principles of an Investigator Initiated Satellite Symposium are that it should be complementary to and be additive to the ISH scientific program, it should not be competitive with the ISH meeting in theme, content or need for financial resources. Registration at the ISH 2010 meeting permits attendance at a Satellite Symposium but Symposia sponsors may charge registration for non-registrants at ISH 2010. Many investigators have found that hosting these symposia are of long term benefit to their research group, academic institution or research area of interest. If you are interested in organizing an Investigator Initiated Satellite Symposium, kindly contact either:

Frans HH Leenen, MD PhD FRCPC FAHA

Professor of Medicine & Pharmacology University of Ottawa
Director, Hypertension Unit, University of Ottawa Heart Institute
Pfizer Chair in Hypertension Research
Email: fleenen@ottawaheart.ca

George Fodor MD PhD FRCPC FAHA

Professor of Medicine & Pharmacology University of Ottawa
Head of Prevention and Rehabilitation Research, University of Ottawa Heart Institute
Email: Gfodor@ottawaheart.ca

Confirmed Investigator Initiated Satellite Symposia

For more details on the confirmed Symposia, click on the links below:

The Pathogenesis of Essential Hypertension: Focus on Salt, Stress and Obesity

Retinal Vessel Analysis - From Risk Assessment to Therapy

The Heart and Kidney Interface and the CardioRenal Syndrome

Behavioral Cardiology and Hypertension: Current Developments in Assessment and Intervention

The Endocrine Heart - 30 Years Later

The Pathogenesis of Essential Hypertension: Focus on Salt, Stress and Obesity

Symposium Chair: Paul Korner
Contact Information: pkorner@bigpond.net.au
Date: Friday, September 24 to Sunday, September 26
Location: The Westin Resort and Spa, Whistler, British Columbia
Contact Information: Frans Leenen
Email: fleenen@ottawaheart.ca
For additional information please visit the Symposium Website

This symposium will provide the opportunity of discussing the mechanisms by which the elevation of blood pressure is influenced by genes and environmental factors related to lifestyle, including high salt intake, stress and obesity. Some of these factors act on several components of the cardiovascular control system, which will undoubtedly result in vigorous debate as to their relative importance. Lastly, there will be discussion of how the new pathophysiological insights result in better treatment or even prevention.

To view the complete program please click here.

Retinal Vessel Analysis - From Risk Assessment to Therapy

Session Co-Chairs: Leopold Schmetterer and Arno Schmidt-Trucksäss
Date: Sunday, September 26
Location: Vancouver Convention Centre
Time: 14:00 - 16:30pm
Contact Information: Prof. Arno Schmidt-Trucksäss, MD, MA
Deputy Director Institute Exercise and Health Sciences, Head Department Sports Medicine
Professor and Chair Sports Medicine, University of Basel
Email: Arno.Schmidt-Trucksaess@unibas.ch

Presentations:
Physiological regulation of retinal vessel diameter and blood flow
Tjalf Ziemssen, Research Group Neuro-Metabolism, University Hospital Dresden, Germany

Assessment of retinal structure and function by static and dynamic vessel analysis
Gerhard Garhoefer, Dpt Ophthalmology, University of Vienna, Vienna, Austria

Association of atherosclerotic risk factors and cardio-vascular outcome with retinal structure and function
Arno Schmidt-Trucksaess, Dpt Sportsmedicine, Medical Faculty, University Basel, Basel

Lifestyle and retinal microcirculation
Henner Hanssen, Dpt Sportsmedicine, Medical Faculty, University Basel, Basel

Benefit of pharmacologic treatment on retinal blood flow
Leopold Schmetterer, Dpt Clinical Pharmacology, University of Vienna, Vienna, Austria

The Heart and Kidney Interface and the CardioRenal Syndrome

Session Chair: Branko Braam
Date: Sunday, September 26
Location: Vancouver Convention Centre
Time: 8:00am - 11:45am
Contact Information: Branko Braam, MD, PhD, FASN
Associate Professor of Medicine, University of Alberta Hospital
Adjunct Associate Professor of Physiology
Heart and Stroke Foundation of Canada New Investigator
Email: branko.braam@ualberta.ca

Presentations:
Part 1 (8:00-9:00): Pathophysiology of the CRS
Arterial and venous pressure regulation in the CRS
Hans Hillege, Groningen, Netherlands

Non-hemodynamic coupling between Heart and Kidneys
Branko Braam, University of Alberta Hospital, Canada

Part 2 (9:00-10:00): Definition, Classification and Epidemiology of the CRS
Classification of the CRS
Philip Kalra, Salford, United Kingdom

Operational definitions and epidemiology of CRS
Sean Bagshaw, Edmonton, Canada

Break (10:00-10:15)

Part 3 (10:15-11:45): Clinical aspects of the CRS
Diagnosis and treatment of anemia in kidney and heart failure
Carlo Gaillard, Free University Medical Center, Amsterdam

Relationships between heart failure and renal failure in acute and chronic settings
Justin Ezekowitz, Edmonton, Canada

Heading for a research agenda: Where are the questions in this field.
John Floras, University of Toronto, Canada

Behavioral Cardiology and Hypertension: Current Developments in Assessment and Intervention

Session Co-Chairs: Robert P. Nolan and John S. Floras
Date: Saturday, September 25
Location: Vancouver Convention Centre
Time: 13:00 - 16:30
Contact Information: Robert P. Nolan, PhD, C.Psych.
Director, Behavioural Cardiology Research Unit University Health
Network Assist. Prof., Institute of Medical Sciences and Department of Psychiatry, Faculty of Medicine, University of Toronto
Email: rnolan@uhnres.utoronto.ca

This symposium will present novel initiatives within behavioral cardiology for the assessment and treatment of hypertension, using research methods from cardiovascular neuroscience, neuroimaging, exercise physiology, nutrition sciences, and behavioral psychology. This multidisciplinary symposium will include 7 25-minute presentations (one of which is by a Discussant). Each presentation will be followed by a 5-minute question period.

Presentations:
Lifestyle measures in the treatment of high blood pressure: Insights from the ENCORE study
Alan Hinderliter, University of North Carolina, USA

The use of brief aerobic exercise and postural maneuvers to evaluate the dynamic regulation of blood pressure
Scott G. Thomas, University of Toronto, Canada

Assessment of the cortical autonomic network and cardiovagal modulationin health and hypertension during submaximal handgrip
J. Kevin Shoemaker, University of Western Ontario, Canada

Human neuroimaging assessments of blood pressure reactivity to mental stress: Relevance for understanding cardiovascular disease risk.
Peter J. Gianaros, University of Pittsburgh, USA

Dynamic interactions between musical, cardiovascular and cerebral rhythms
Luciano Bernardi, University of Pavia, Italy

Behavioral neurocardiac training with heart rate variability biofeedback: A novel intervention for hypertension
Robert P. Nolan, University Health Network and University of Toronto, Canada

Discussant
John S. Floras, University Health Network and University of Toronto, Canada

The Endocrine Heart - 30 Years Later

Session Chair: Adolfo J. de Bold
Date: Thursday, September 23 to Friday, September 24
Location: Ottawa, Ontario
Contact Information: Dr. Mona Nemer, University of Ottawa or Dr. Robert Roberts, University of Ottawa Heart Institute
Email: anfsymp@ottawaheart.ca
For additional information please visit the Symposium Website

The Endocrine Heart: 30 Years Later is a special scientific symposium commemorating the thirtieth anniversary of the discovery of atrial natriuretic factor (ANF). The discovery established that the heart possesses an endocrine function. This landmark was recognized by the first ever Canadian Institutes of Health Research/Canadian Medical Association Journal top Canadian Achievement in Health Research Award in 2009 and acknowledged as one of the top 10 research discoveries in the past 50 years by the Heart and Stroke Foundation of Ontario.

^ top